Document

Silicon Labs Reports Fourth Quarter and Full Year 2025 Results

AUSTIN, Texas – February 4, 2026 – Silicon Labs (NASDAQ: SLAB), a leader in secure, intelligent wireless technology for a more connected world, reported financial results for the fourth quarter and full year 2025, which ended January 3, 2026.

“The Silicon Labs team completed fiscal 2025 with continued strong execution, delivering an impressive year-over-year revenue growth of 34%,” said Matt Johnson, President and Chief Executive Officer of Silicon Labs. “That momentum continues as we enter 2026 with record opportunity funnel and design win traction.”

Due to the separately announced pending acquisition of Silicon Labs by Texas Instruments, Silicon Labs will cancel its previously announced earnings call scheduled for February 10, 2026, and has suspended providing forward-looking guidance.

Full Year 2025 Financial Highlights

•Revenue was $785 million, up 34% year-over-year

•Industrial & Commercial revenue for the year was $445 million, up 31% year-over-year

•Home & Life revenue for the year was $340 million, up 38% year-over-year

Results on a GAAP basis:

•GAAP gross margin was 58.2%

•GAAP operating expenses were $528 million

•GAAP operating loss was $71 million

•GAAP diluted loss per share was $(1.98)

Results on a non-GAAP basis, excluding the impact of stock compensation, amortization of acquired intangible assets, and certain other items as set forth in the below GAAP to Non-GAAP reconciliation tables were as follows:

•Non-GAAP gross margin was 58.5%

•Non-GAAP operating expenses were $434 million

•Non-GAAP operating income was $25 million

•Non-GAAP diluted earnings per share was $0.92

Fourth Quarter Financial Highlights

•Revenue was $208 million, up 25% year-over-year

•Industrial & Commercial revenue for the quarter was $122 million, up 37% year-over-year

•Home & Life revenue for the quarter was $87 million, up 12% year-over-year

Results on a GAAP basis:

•GAAP gross margin was 63.4%

•GAAP operating expenses were $135 million

•GAAP operating loss was $3 million

•GAAP diluted loss per share was $(0.08)

•Non-GAAP gross margin was 63.6%

•Non-GAAP operating expenses were $112 million

•Non-GAAP operating income was $21 million

•Non-GAAP diluted earnings per share was $0.56

Silicon Labs (NASDAQ: SLAB) is the leading innovator in low-power wireless connectivity, building embedded technology that connects devices and improves lives. Merging cutting-edge technology into the world's most highly integrated SoCs, Silicon Labs provides device makers the solutions, support, and ecosystems needed to create advanced edge connectivity applications. Headquartered in Austin, Texas, Silicon Labs has operations in over 16 countries and is the trusted partner for innovative solutions in the smart home, industrial IoT, and smart cities markets. Learn more at silabs.com.

Forward-Looking Statements

This press release contains forward-looking statements based on Silicon Labs’ current expectations. The words “believe”, “estimate”, “expect”, “intend”, “anticipate”, “plan”, “project”, “will”, and similar phrases as they relate to Silicon Labs are intended to identify such forward-looking statements. These forward-looking statements reflect the current views and assumptions of Silicon Labs and are subject to various risks and uncertainties that could cause actual results to differ materially from expectations. Among the factors that could cause actual results to differ materially from those in the forward-looking statements are the following: fluctuating changes in global trade policies, including the imposition of tariffs, duties, trade sanctions, or other barriers to international commerce; the impact of the current global memory chip shortage; the competitive and cyclical nature of the semiconductor industry; the challenging macroeconomic environment, including disruptions in the financial services industry; geographic concentration of manufacturers, assemblers, test service providers and customers in Asia that subjects Silicon Labs’ business and results of operations to risks of natural disasters, epidemics or pandemics, war and political unrest; risks that demand and the supply chain may be adversely affected by military conflict (including in the Middle East, and between Russia and Ukraine), terrorism, sanctions or other geopolitical events globally (including in the Middle East, and conflict between Taiwan and China); risks that Silicon Labs may not be able to maintain its historical growth; quarterly fluctuations in revenues and operating results; difficulties developing new products that achieve market acceptance; risks associated with international activities (including trade barriers, particularly with respect to China); intellectual property litigation risks; risks associated with acquisitions and divestitures; product liability risks; difficulties managing and/or obtaining sufficient supply from Silicon Labs’ distributors, manufacturers and subcontractors; dependence on a limited number of products; absence of long-term commitments from customers; inventory-related risks; difficulties managing international activities; risks that Silicon Labs may not be able to manage strains associated with its growth; credit risks associated with its accounts receivable; dependence on key personnel; stock price volatility; the impact of public health crises on the U.S. and global economy; debt-related risks; capital-raising risks; the timing and scope of share repurchases and/or dividends; average selling prices of products may decrease significantly and rapidly; information technology risks; cyber-attacks against Silicon Labs’ products and its networks; risks associated with any material weakness in our internal controls over financial reporting; risks relating to compliance with laws and regulations; and other factors that are detailed in the SEC filings of Silicon Laboratories Inc. Silicon Labs disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. References in this press release to Silicon Labs shall mean Silicon Laboratories Inc.

Note to editors: Silicon Laboratories, Silicon Labs, the “S” symbol, and the Silicon Labs logo are trademarks of Silicon Laboratories Inc. All other product names noted herein may be trademarks of their respective holders.

Silicon Laboratories Inc.

Condensed Consolidated Statements of Operations

(In thousands, except per share data)


	Three Months Ended				Year Ended
	January 3, 2026		December 28, 2024		January 3, 2026		December 28, 2024
Revenues	$	208,206	$	166,249	$	784,764	$	584,386
Cost of revenues	76,128		76,026		327,781		272,198
Gross profit	132,078		90,223		456,983		312,188
Operating expenses:
Research and development	89,521		82,438		353,246		332,225
Selling, general and administrative	45,809		36,412		174,278		145,453
Operating expenses	135,330		118,850		527,524		477,678
Operating loss	(3,252)		(28,627)		(70,541)		(165,490)
Other income (expense):
Interest income and other, net	2,932		2,978		13,604		11,987
Interest expense	(214)		(260)		(975)		(1,310)
Loss before income taxes	(534)		(25,909)		(57,912)		(154,813)
Provision (benefit) for income taxes	2,150		(2,086)		6,995		36,197

Net loss	$	(2,684)	$	(23,823)	$	(64,907)	$	(191,010)

Loss per share:
Basic	$	(0.08)	$	(0.73)	$	(1.98)	$	(5.93)
Diluted	$	(0.08)	$	(0.73)	$	(1.98)	$	(5.93)

Weighted-average common shares outstanding:
Basic	32,920		32,420		32,721		32,191
Diluted	32,920		32,420		32,721		32,191

Non-GAAP Financial Measurements

In addition to the GAAP results provided throughout this document, Silicon Labs has provided non-GAAP financial measurements on a basis excluding non-cash and other charges and benefits. Details of these excluded items are presented in the tables below, which reconcile the GAAP results to non-GAAP financial measurements.

The non-GAAP financial measurements do not replace the presentation of Silicon Labs’ GAAP financial results. These measurements provide supplemental information to assist management and investors in analyzing Silicon Labs’ financial position and results of operations. Silicon Labs has chosen to provide this information to investors to enable them to perform meaningful comparisons of past, present and future operating results and as a means to emphasize the results of core on-going operations.

Unaudited Reconciliation of GAAP to Non-GAAP Financial Measures

(In thousands, except per share data)


	Three Months Ended January 3, 2026
Non-GAAP Income Statement Items	GAAP Measure		GAAP Percent of Revenue		Stock Compensation Expense		Intangible Asset Amortization		Other Costs		Non-GAAP Measure		Non-GAAP Percent of Revenue
Revenues	$	208,206

Gross profit	132,078		63.4	%	$	400	$	—	$	—	$	132,478	63.6	%

Research and development	89,521		43.0	%	12,190		2,295		404		74,632		35.8	%

Selling, general and administrative	45,809		22.0	%	8,089		—		461		37,259		17.9	%

Operating expenses	135,330		65.0	%	20,279		2,295		865		111,891		53.7	%

Operating income (loss)	(3,252)		(1.6	%)	20,679		2,295		865		20,587		9.9	%


	Three Months Ended January 3, 2026
Non-GAAP Earnings (Loss) Per Share	GAAP Measure		Stock Compensation Expense*		Intangible Asset Amortization*		Other Costs*		Income Tax Adjustments		Non- GAAP Measure
Net income (loss)	$	(2,684)	$	20,679	$	2,295	$	865	$	(2,511)	$	18,644
			Shares Excluded Due to Net Loss
Diluted shares outstanding	32,920		279								33,199

Diluted earnings (loss) per share	$	(0.08)									$	0.56

*Represents pre-tax amounts


	Twelve Months Ended January 3, 2026
Non-GAAP Income Statement Items	GAAP Measure		GAAP Percent of Revenue		Stock Compensation Expense		Intangible Asset Amortization		Other Costs		Non-GAAP Measure		Non-GAAP Percent of Revenue
Revenues	$	784,764

Gross profit	456,983		58.2	%	$	1,944	$	—	$	—	$	458,927	58.5	%

Research and development	353,246		45.0	%	48,447		13,369		934		290,496		37.0	%

Selling, general and administrative	174,278		22.2	%	29,933		—		1,216		143,129		18.2	%

Operating expenses	527,524		67.2	%	78,380		13,369		2,150		433,625		55.3	%

Operating income (loss)	(70,541)		(9.0	%)	80,324		13,369		2,150		25,302		3.2	%


	Twelve Months Ended January 3, 2026
Non-GAAP Earnings (Loss) Per Share	GAAP Measure		Stock Compensation Expense*		Intangible Asset Amortization*		Other Costs*		Income Tax Adjustments		Non- GAAP Measure
Net income (loss)	$	(64,907)	$	80,324	$	13,369	$	2,150	$	(591)	$	30,345
			Shares Excluded Due to Net Loss
Diluted shares outstanding	32,721		260								32,981

Diluted earnings (loss) per share	$	(1.98)									$	0.92

*Represents pre-tax amounts

Silicon Laboratories Inc.

Condensed Consolidated Balance Sheets

(In thousands, except per share data)


	January 3, 2026		December 28, 2024
Assets
Current assets:
Cash and cash equivalents	$	364,222	$	281,607
Short-term investments	79,400		100,554
Accounts receivable, net	64,513		54,479
Inventories	95,566		105,639
Prepaid expenses and other current assets	70,316		59,754
Total current assets	674,017		602,033
Property and equipment, net	128,643		132,136
Goodwill	376,389		376,389
Other intangible assets, net	23,130		36,499
Other assets, net	67,138		75,617
Total assets	$	1,269,317	$	1,222,674
Liabilities and Stockholders’ Equity
Current liabilities:
Accounts payable	$	50,717	$	42,448

Deferred revenue and returns liability	5,359		3,073
Other current liabilities	87,711		52,362
Total current liabilities	143,787		97,883

Other non-current liabilities	31,112		44,770
Total liabilities	174,899		142,653
Commitments and contingencies
Stockholders’ equity:
Preferred stock – $0.0001 par value; 10,000 shares authorized; no shares issued	—		—
Common stock – $0.0001 par value; 250,000 shares authorized; 32,955 and 32,458 shares issued and outstanding at January 3, 2026 and December 28, 2024, respectively	3		3
Additional paid-in capital	157,402		78,227
Retained earnings	936,814		1,001,721
Accumulated other comprehensive income	199		70
Total stockholders’ equity	1,094,418		1,080,021
Total liabilities and stockholders’ equity	$	1,269,317	$	1,222,674

Silicon Laboratories Inc.

Condensed Consolidated Statements of Cash Flows


	Year Ended
	January 3, 2026		December 28, 2024
Operating Activities
Net loss	$	(64,907)	$	(191,010)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation of property and equipment	24,716		25,551
Amortization of other intangible assets	13,369		23,034


Stock-based compensation expense	80,324		61,503

Deferred income taxes	881		29,470
Changes in operating assets and liabilities:
Accounts receivable	(10,034)		(25,184)
Inventories	9,992		88,494
Prepaid expenses and other assets	8,826		27,362
Accounts payable	6,333		(15,155)
Other current liabilities and income taxes	36,781		(21,768)
Deferred revenue and returns liability	2,286		956
Other non-current liabilities	(12,859)		(17,163)
Net cash provided by (used in) operating activities	95,708		(13,910)

Investing Activities
Purchases of marketable securities	(34,790)		(73,602)
Sales of marketable securities	15,393		54,227
Maturities of marketable securities	40,716		131,858
Purchases of property and equipment	(29,922)		(11,748)
Proceeds from capital-related government incentives	578		—
Proceeds from sale of equity investment	—		12,382
Purchases of other assets	(4,000)		—
Net cash provided by (used in) investing activities	(12,025)		113,117

Financing Activities

Payments on debt	—		(45,000)
Repurchases of common stock	—		(16)
Payment of taxes withheld for vested stock awards	(15,706)		(16,434)
Proceeds from the issuance of common stock	14,638		16,346
Net cash used in financing activities	(1,068)		(45,104)

Increase in cash and cash equivalents	82,615		54,103
Cash and cash equivalents at beginning of period	281,607		227,504
Cash and cash equivalents at end of period	$	364,222	$	281,607